73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Metastatic cancers adapt their metabolism to the tissue in which they grow

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre
CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-
Researchers discover iron-targeting approaches to halt proliferation of cancer cells

Researchers discover iron-targeting approaches to halt proliferation of cancer cells

by University of Arizona(From left) Yu-Shien Sung, doctoral student in the Tomat Lab, and University of Arizona Cancer Center member Elisa Tomat, PhD, are studying an iron-targeting molecule that

Researchers discover iron-targeting approaches to halt proliferation of cancer cells

by University of Arizona(From left) Yu-Shien Sung, doctoral student in the Tomat Lab, and University of Arizona Cancer Center member Elisa Tomat, PhD, are studying an iron-targeting molecule that
Scientists develop a rapid gene-editing screen to find effects of cancer mutations

Scientists develop a rapid gene-editing screen to find effects of cancer mutations

by Massachusetts Institute of TechnologyDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHTumors can carry mutations in hundreds of different gen

Scientists develop a rapid gene-editing screen to find effects of cancer mutations

by Massachusetts Institute of TechnologyDNA, which has a double-helix structure, can have many genetic mutations and variations. Credit: NIHTumors can carry mutations in hundreds of different gen
First screening test for detecting lymph node metastasis in pancreatic cancer patients

First screening test for detecting lymph node metastasis in pancreatic cancer patients

by City of HopeAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainFor years, surgeons have operated on pancreatic cancer patients to remove what

First screening test for detecting lymph node metastasis in pancreatic cancer patients

by City of HopeAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainFor years, surgeons have operated on pancreatic cancer patients to remove what
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d
ACS sets goal to cut cancer mortality 40 percent by 2035

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for

ACS sets goal to cut cancer mortality 40 percent by 2035

(HealthDay)—The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 inCA: A Cancer Journal for
Overall, drinking wine does not impact prostate cancer risk

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,

Overall, drinking wine does not impact prostate cancer risk

(HealthDay)—Moderate wine consumption does not seem to impact the risk of prostate cancer, according to a review published online April 17 inClinical Epidemiology.Mihai Dorin Vartolomei, Ph.D.,
Researchers discover factors that two aggressive cancers have in common

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed
Genetically modified herpes virus delivers one-two punch against advanced cancers

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c
Seeing prostate cancer in a new light

Seeing prostate cancer in a new light

by University of DundeeCredit: University of DundeeA new method offering more successful diagnosis and management of prostate cancer has been identified by researchers at the University of Dundee

Seeing prostate cancer in a new light

by University of DundeeCredit: University of DundeeA new method offering more successful diagnosis and management of prostate cancer has been identified by researchers at the University of Dundee